Paper810282
Cytotoxic lymphocytes from normal donors. A functional marker of human non-T lymphocytes.
Pross HF and 1 other. Clin Exp Immunol, 1975. Cited by 219 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Cytotoxic lymphocytes from normal donors. A functional marker of human non-T lymphocytes. Papers, record 810282. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/810282
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cytotoxic lymphocytes from normal donors. A functional marker of human non-T lymphocytes.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Lymphocytes | Major topic |
| Animals | |
| Blood Donors | |
| Cell Line | |
| Cytotoxicity Tests, Immunologic | |
| Fluorescent Antibody Technique | |
| Humans | |
| Immune Adherence Reaction | |
| Kinetics | |
| Mast-Cell Sarcoma | |
| Mice | |
| Neoplasms, Experimental | |
| Phagocytes | |
| Sheep | |
| T-Lymphocytes | |
| Time Factors |
Source PubMed
References18
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4,101,362 | A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization. | J Exp Med | 1970 | https://conductscience.org/library/papers/4101362 | PubMed |
| 2 | 4,132,264 | Formation of mouse or sheep red-blood-cell rosettes by lymphocytes from normal and leukaemic individuals. | Lancet | 1974 | https://conductscience.org/library/papers/4132264 | PubMed |
| 3 | 4,357,682 | Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus receptors on B lymphocytes. | J Exp Med | 1973 | https://conductscience.org/library/papers/4357682 | PubMed |
| 4 | 4,272,900 | Human lymphocyte subpopulations: classification according to surface markers and-or functional characteristics. | Transplant Rev | 1973 | https://conductscience.org/library/papers/4272900 | PubMed |
| 5 | 4,210,390 | Relations of HL-A and Rh systems to immune reactivity. Joint report of the results of 'HL-A and immune response' workshop, Budapest 1972. | Vox Sang | 1974 | https://conductscience.org/library/papers/4210390 | PubMed |
| 6 | 4,617,294 | Surface markers on human B and T lymphocytes. IV. Distribution of surface markers on resting and blast-transformed lymphocytes. | Scand J Immunol | 1974 | https://conductscience.org/library/papers/4617294 | PubMed |
| 7 | 4,587,740 | A rapid method for the isolation of functional thymus-derived murine lymphocytes. | Eur J Immunol | 1973 | https://conductscience.org/library/papers/4587740 | PubMed |
| 8 | 4,512,889 | Cytotoxicity of a factor isolated from human spleen. | J Natl Cancer Inst | 1973 | https://conductscience.org/library/papers/4512889 | PubMed |
| 9 | 4,768,397 | HL-A antigens and diseases. I. Multiple sclerosis. | Tissue Antigens | 1973 | https://conductscience.org/library/papers/4768397 | PubMed |
| 10 | 4,655,776 | HL-A antigens and multiple sclerosis. | Tissue Antigens | 1972 | https://conductscience.org/library/papers/4655776 | PubMed |
| 11 | 5,077,731 | Multiple sclerosis: association with HL-A3. | Tissue Antigens | 1972 | https://conductscience.org/library/papers/5077731 | PubMed |
| 12 | 5,718,505 | Differential effects of human granulocytes and lymphocytes on human fibroblasts in vitro. | Clin Exp Immunol | 1968 | https://conductscience.org/library/papers/5718505 | PubMed |
| 13 | 5,706,694 | An extension of the 51Cr-release assay for the estimation of mouse cytotoxins. | Transplantation | 1968 | https://conductscience.org/library/papers/5706694 | PubMed |
| 14 | 14,285,093 | QUANTITATIVE TITRATIONS OF MOUSE H-2 ANTIBODIES USING CR-51-LABELLED TARGET CELLS. | Transplantation | 1965 | https://conductscience.org/library/papers/14285093 | PubMed |
| 15 | 13,758,706 | An antibody-complement system in normal serum lethal to mouse tumor cells. | Cancer Res | 1960 | https://conductscience.org/library/papers/13758706 | PubMed |
| 17 | 4,114,496 | Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells. | J Exp Med | 1972 | https://conductscience.org/library/papers/4114496 | PubMed |
| 18 | 4,132,457 | Letter: HL-A 3,7 and lymphocyte cytotoxic activity. | Lancet | 1974 | https://conductscience.org/library/papers/4132457 | PubMed |
| 19 | 4,151,339 | Cell-mediated cytotoxicity, allograft rejection, and tumor immunity. | Adv Immunol | 1974 | https://conductscience.org/library/papers/4151339 | PubMed |
Cited by53
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 219 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38,842,526 | Five decades of natural killer cell discovery. | J Exp Med | 2024 | https://conductscience.org/library/papers/38842526 | PubMed |
| 38,545,115 | Therapeutic approaches to enhance natural killer cell cytotoxicity. | Front Immunol | 2024 | https://conductscience.org/library/papers/38545115 | PubMed |
| 37,872,958 | Combination of NK and Other Immune Markers at Early Phase Stratify the Risk of Sepsis Patients: A Retrospective Study. | J Inflamm Res | 2023 | https://conductscience.org/library/papers/37872958 | PubMed |
| 36,848,790 | Highlights into historical and current immune interventions for cancer. | Int Immunopharmacol | 2023 | https://conductscience.org/library/papers/36848790 | PubMed |
| 36,776,839 | Natural killer cells in sepsis: Friends or foes? | Front Immunol | 2023 | https://conductscience.org/library/papers/36776839 | PubMed |
| 36,232,666 | Evaluating the Safety and Quality of Life of Colorectal Cancer Patients Treated by Autologous Immune Enhancement Therapy (AIET) in Vinmec International Hospitals. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36232666 | PubMed |
| 35,639,116 | Natural killer cells and acute myeloid leukemia: promises and challenges. | Cancer Immunol Immunother | 2022 | https://conductscience.org/library/papers/35639116 | PubMed |
| 35,203,349 | Defective Patient NK Function Is Reversed by AJ2 Probiotic Bacteria or Addition of Allogeneic Healthy Monocytes. | Cells | 2022 | https://conductscience.org/library/papers/35203349 | PubMed |
| 33,717,125 | The Role of Natural Killer Cells in Autoimmune Diseases. | Front Immunol | 2021 | https://conductscience.org/library/papers/33717125 | PubMed |
| 33,193,374 | Neural Regulation of Interactions Between Group 2 Innate Lymphoid Cells and Pulmonary Immune Cells. | Front Immunol | 2020 | https://conductscience.org/library/papers/33193374 | PubMed |
| 32,133,731 | Non-clinical efficacy, safety and stable clinical cell processing of induced pluripotent stem cell-derived anti-glypican-3 chimeric antigen receptor-expressing natural killer/innate lymphoid cells. | Cancer Sci | 2020 | https://conductscience.org/library/papers/32133731 | PubMed |
| 31,921,205 | The Intriguing History of Cancer Immunotherapy. | Front Immunol | 2019 | https://conductscience.org/library/papers/31921205 | PubMed |
| 31,456,803 | CD8+ T Lymphocyte and NK Cell Network: Circuitry in the Cytotoxic Domain of Immunity. | Front Immunol | 2019 | https://conductscience.org/library/papers/31456803 | PubMed |
| 30,671,486 | Effect of Natural Compounds on NK Cell Activation. | J Immunol Res | 2018 | https://conductscience.org/library/papers/30671486 | PubMed |
| 30,150,991 | Natural Killer Cells: Development, Maturation, and Clinical Utilization. | Front Immunol | 2018 | https://conductscience.org/library/papers/30150991 | PubMed |
| 28,842,470 | IL15 Infusion of Cancer Patients Expands the Subpopulation of Cytotoxic CD56bright NK Cells and Increases NK-Cell Cytokine Release Capabilities. | Cancer Immunol Res | 2017 | https://conductscience.org/library/papers/28842470 | PubMed |
| 28,060,858 | Fermented Papaya Preparation Restores Age-Related Reductions in Peripheral Blood Mononuclear Cell Cytolytic Activity in Tube-Fed Patients. | PLoS One | 2017 | https://conductscience.org/library/papers/28060858 | PubMed |
| 26,706,497 | Phenotype and functions of conventional and non-conventional NK cells. | Curr Opin Immunol | 2016 | https://conductscience.org/library/papers/26706497 | PubMed |
| 26,121,198 | Innate lymphoid cells in the initiation, regulation and resolution of inflammation. | Nat Med | 2015 | https://conductscience.org/library/papers/26121198 | PubMed |
| 24,058,177 | The host environment is responsible for aging-related functional NK cell deficiency. | J Immunol | 2013 | https://conductscience.org/library/papers/24058177 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/810282
GET https://conductscience.org/api/papers/v1/810282/cited_by?page=2